Exalt3: Phase 3 Randomized Study Comparing Ensartinib To Crizotinib In Anaplastic Lymphoma Kinase (Alk) Positive Non-Small Cell Lung Cancer (Nsclc) Patients
JOURNAL OF THORACIC ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF THORACIC ONCOLOGY(2018)